Literature DB >> 23776159

Anthracimycin, a potent anthrax antibiotic from a marine-derived actinomycete.

Kyoung Hwa Jang1, Sang-Jip Nam, Jeffrey B Locke, Christopher A Kauffman, Deanna S Beatty, Lauren A Paul, William Fenical.   

Abstract

Licensed to kill: A new antibiotic, anthracimycin (see scheme), produced by a marine-derived actinomycete in saline culture, shows significant activity toward Bacillus anthracis, the bacterial pathogen responsible for anthrax infections. Chlorination of anthracimycin gives a dichloro derivative that retains activity against Gram-positive bacteria, such as anthrax, but also shows activity against selected Gram-negative bacteria.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  anthrax; antibiotics; bacillus anthracis; natural products; polyketides

Mesh:

Substances:

Year:  2013        PMID: 23776159      PMCID: PMC3821700          DOI: 10.1002/anie.201302749

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  2 in total

1.  The total synthesis of chlorotonil A.

Authors:  Nicola Rahn; Markus Kalesse
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

2.  Chlorotonil A, a macrolide with a unique gem-dichloro-1,3-dione functionality from Sorangium cellulosum, So ce1525.

Authors:  Klaus Gerth; Heinrich Steinmetz; Gerhard Höfle; Rolf Jansen
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

  2 in total
  36 in total

1.  Asymmetric Total Synthesis of the Naturally Occurring Antibiotic Anthracimycin.

Authors:  Emma K Davison; Jared L Freeman; Wanli Zhang; William M Wuest; Daniel P Furkert; Margaret A Brimble
Journal:  Org Lett       Date:  2020-06-29       Impact factor: 6.005

2.  Biosynthetic origin of anthracimycin: a tricyclic macrolide from Streptomyces sp.

Authors:  Enjuro Harunari; Hisayuki Komaki; Yasuhiro Igarashi
Journal:  J Antibiot (Tokyo)       Date:  2015-12-02       Impact factor: 2.649

Review 3.  Streptomycetes: Surrogate hosts for the genetic manipulation of biosynthetic gene clusters and production of natural products.

Authors:  Keshav K Nepal; Guojun Wang
Journal:  Biotechnol Adv       Date:  2018-10-09       Impact factor: 14.227

4.  The 160K Natural Organism Library, a unique resource for natural products research.

Authors:  Siew Bee Ng; Yoganathan Kanagasundaram; Hao Fan; Prakash Arumugam; Birgit Eisenhaber; Frank Eisenhaber
Journal:  Nat Biotechnol       Date:  2018-07-06       Impact factor: 54.908

5.  Synergistic interactions of vancomycin with different antibiotics against Escherichia coli: trimethoprim and nitrofurantoin display strong synergies with vancomycin against wild-type E. coli.

Authors:  Alice Zhou; Tina Manzhu Kang; Jessica Yuan; Casey Beppler; Caroline Nguyen; Zhiyuan Mao; Minh Quan Nguyen; Pamela Yeh; Jeffrey H Miller
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

Review 6.  Designing inhibitors of anthrax toxin.

Authors:  Ekaterina M Nestorovich; Sergey M Bezrukov
Journal:  Expert Opin Drug Discov       Date:  2014-01-22       Impact factor: 6.098

7.  Antimalarial activity of the myxobacterial macrolide chlorotonil a.

Authors:  Jana Held; Tamirat Gebru; Markus Kalesse; Rolf Jansen; Klaus Gerth; Rolf Müller; Benjamin Mordmüller
Journal:  Antimicrob Agents Chemother       Date:  2014-08-11       Impact factor: 5.191

8.  Production of macrolide antibiotics from a cytotoxic soil Streptomyces sp. strain ZDB.

Authors:  Zerihun T Dame; Pornthip Ruanpanun
Journal:  World J Microbiol Biotechnol       Date:  2017-06-05       Impact factor: 3.312

Review 9.  Antimicrobial compounds from marine actinomycetes.

Authors:  Cong Wang; Yuanyu Lu; Shugeng Cao
Journal:  Arch Pharm Res       Date:  2020-07-20       Impact factor: 4.946

10.  Actinoquinolines A and B, anti-inflammatory quinoline alkaloids from a marine-derived Streptomyces sp., strain CNP975.

Authors:  Hossam M Hassan; Chollaratt Boonlarppradab; William Fenical
Journal:  J Antibiot (Tokyo)       Date:  2016-05-25       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.